Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute of Allergy and Infectious Diseases (NIAID)
The study enrolls 90 transplant recipients with positive nasal/throat culture specimens for Respiratory Syncytial Virus (RSV) infection. Patients are randomized into one of two groups: investigational treatment or standard treatment.
Age
5–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
2 years of age or older.
Are not pregnant or breast-feeding and agree to use a reliable birth control method for the duration of the study.
Are a blood or bone marrow transplant recipient.
Have evidence of upper respiratory tract infection.
Have nasopharyngeal-throat samples positive for RSV.
You may not be if
Are known to be HIV positive.
Have pneumonia.
Require a ventilator to breathe.
Are pregnant.
Are breast-feeding and are unwilling to stop breast-feeding.
Are receiving treatment with certain other drugs for RSV.
Clareo Health | Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients
